Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes.

Advances in clinical chemistry - 1 Jan 2023

Bougea Anastasia, Stefanis Leonidas

Abstract excerpt

Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are atypical parkinsonian syndromes (APS) with various clinical phenotypes and considerable clinical overlap with idiopathic Parkinson's disease (iPD). This disease heterogeneity makes ante-mortem diagnosis extremely challenging with up to 24% of patients misdiagnosed. Because diagnosis is predominantly clinical, there is great interest in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNAs
Share to Parkinson Disease
Share to Parkinsonian Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to RNA, Circular

Source

Identifiers

PMID: 37673523
DOI: 10.1016/bs.acc.2023.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes.PMID 37673523Read ↗

ROLE OF MICRORNAS IN THE PATHOGENESIS OF PARKINSON'S DISEASESemantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

Circulating blood circular RNA in Parkinson’s Disease; a systematic studySemantic proximity Read ↗

Identification of a circRNA-miRNA-mRNA interactome associated with Parkinson’s Disease progressionSemantic proximity Read ↗

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s DiseaseSemantic proximity Read ↗

<i>CircEPS15</i>, as a sponge of <i>MIR24-3p</i> ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagySemantic proximity Read ↗

Parkinson’s disease is associated with an imbalance in circular RNA expressionSemantic proximity Read ↗

Circular RNAs in Parkinson’s Disease: Reliable Biological markers and targets for RehabilitationSemantic proximity Read ↗

Differentially expressed circular RNAs in peripheral blood mononuclear cells of PD patientsSemantic proximity Read ↗

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s DiseaseSemantic proximity Read ↗

Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesisSemantic proximity Read ↗

Mitochondria-Associated MicroRNAs and Parkinson’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.